At Diversigen, we are applying metagenomics to benefit human health, animal health, and to improve environmental conditions and industrial processes worldwide. We are capitalizing on the company’s unique breadth and depth of expertise, reputation and proprietary methods in the exploding field of metagenomics to deliver commercial grade services in this arena. We cater to our customers’ needs, including guaranteed turnaround times and more sensitive levels of QA/QC.
Clinical-Microbiomics is a world-leading contract research organization specialized in microbiome metagenomics. Through state-of-the-art sequencing and development of tailor-made bioinformatics tools, we assist partners across microbiome therapeutics, pharmaceutical, food and nutritional industries to extract key biological insights from microbiome research.
Our proprietary bioinformatics platform and continuous innovation pipeline provides our partners with unmatched capabilities to… Read More
Metabolon, Inc. is the world’s leading health technology company focused on the use of metabolomics in precision medicine and life sciences research. This powerful tool for assessing health is based on proprietary platforms and informatics that deliver biomarker discoveries, innovative diagnostic tests, and ground-breaking partnerships in genomics-based health initiatives.
NIZO is world leading in contract research for better food and health. We believe food and health are becoming increasingly connected. That’s why we are convinced that working closely with our customers, leading food and health companies, is the only road to success. For pharma companies we perform discovery and development programmes related to gut health, oral health and skin health with a specific focus on microbiome modulation.
Founded in 2015 by leading microbiome experts, RondinX is building a cutting-edge target and drug discovery platform set to create solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX core technology, PTR (Peak-to-Trough) family of algorithms, exclusively licensed from YEDA (the commercial arm of the Weizmann Institute of Science), is a proprietary, cloud based, computational pipeline, leveraging raw metagenomics to derive both static and dynamic strain level insights in to the bacterial ecosystem.
SynCo Bio Partners B.V. is a world leading GMP contract manufacturer focused to support its customers with clinical and commercial supply with:
- Microbial drug substance manufacturing; live microbial biotherapeutics, vaccines, proteins and polysaccharides
- Aseptic fill and lyophilization of a wide variety of biologics… Read more
SAMPLE TO SMARTER™
Second Genome Solutions provides end-to-end microbiome research offerings from sample collection to data interpretation with dedicated support from molecular biology and bioinformatics experts every step of the way.
Quay Pharma is experienced in formulation development and is one of very few companies licensed to provide clinical manufacturing materials containing live bacterial strains being targeted for delivery to, and in, the digestive, urogenital, otorhinologic and pulmonary tracts. Understanding the client dosing requirements for the live biotherapeutic… Read More
CosmosID®, based in Rockville, Maryland, is a genomics big data company focused on rapid identification of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications. The CosmosID platform uses proprietary sequence analysis algorithms to accurately profile all microorganisms in a metagenomic sample employing next-generation DNA sequencing.
The BioCollective is a microbiome platform company leveraging stool samples from a direct-to-consumer platform to accelerate research and build a precision medicine discovery platform. We collect extensive life, health history from our member sample providers, including clinical diagnosis when appropriate. This data paired with the sample and basic sequence data provides researchers the ability to select samples and/or participants for research that are more targeted to the therapeutic hypothesis… Read More